Insulin glargine and lixisenatide Subcutaneous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal 13-valent conjugate vaccine
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal Conjugate Vaccine (13-Valent)
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Insulin glargine and lixisenatide Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Insulin glargine, recombinant Subcutaneous
- Pms-Sodium Polystyrene Sulfonate-Insulin glulisine
- Pms-Sodium Polystyrene Sulfonate-Insulin Glulisine (Cartridges and Pens)
- Pms-Sodium Polystyrene Sulfonate-Insulin Glulisine (Vials)
- Pms-Sodium Polystyrene Sulfonate-Insulin glulisine Subcutaneous
- Pms-Sodium Polystyrene Sulfonate-Insulin human inhaled Inhalation